(Q58375684)

English

Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial (English)

0 references

1 reference

1 reference

John W Eikelboom

3

0 references

author name string

Jeremy S Paikin

series ordinal

1

0 references

Michelle J Haroun

series ordinal

2

0 references

publication date

March 2011

0 references

published in

Expert Review of Cardiovascular Therapy

0 references

volume

9

0 references

issue

3

0 references

page(s)

279-286

0 references

cites work

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Oral anticoagulant drugs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERC.11.21

retrieved

21 January 2018

Identifiers

DOI

10.1586/ERC.11.21

0 references

PubMed publication ID

21438804

0 references

(Q58375684)

Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)